rivastigmine sandoz 9.5mg/24 hours transdermal patch
rowex ltd - rivastigmine - transdermal patch - 9.5 milligram(s)/24 hours - anticholinesterases; rivastigmine
rivastigmine sandoz 4.6mg/24 hours transdermal patch
rowex ltd - rivastigmine - transdermal patch - 4.6 milligram(s)/24 hours - anticholinesterases; rivastigmine
rivastigmine 1.5 mg hard capsules
accord healthcare ireland ltd. - rivastigmine - capsule, hard - 1.5 milligram(s) - anticholinesterases; rivastigmine
rivastigmine 3 mg hard capsules
accord healthcare ireland ltd. - rivastigmine - capsule, hard - 3 milligram(s) - anticholinesterases; rivastigmine
rivastigmine 4.5 mg hard capsules
accord healthcare ireland ltd. - rivastigmine - capsule, hard - 4.5 milligram(s) - anticholinesterases; rivastigmine
rivastigmine 6 mg hard capsules
accord healthcare ireland ltd. - rivastigmine - capsule, hard - 6 milligram(s) - anticholinesterases; rivastigmine
exelon 1.5 mg
novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
exelon 3 mg
novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
exelon 4.5 mg
novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.
exelon 6 mg
novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.